RECOMBUMIN Trademark

Trademark Overview


On Thursday, May 26, 2022, a trademark application was filed for RECOMBUMIN with the United States Patent and Trademark Office. The USPTO has given the RECOMBUMIN trademark a serial number of 79345867. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Albumedix Ltd. The RECOMBUMIN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disord...

Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research
recombumin

General Information


Serial Number79345867
Word MarkRECOMBUMIN
Filing DateThursday, May 26, 2022
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7362015
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes
Goods and ServicesChemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code001
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameAlbumedix Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, March 7, 2023ASSIGNED TO EXAMINER
Thursday, July 21, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, July 27, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, July 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022APPLICATION FILING RECEIPT MAILED
Sunday, January 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, March 15, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 3, 2023REFUSAL PROCESSED BY MPU
Wednesday, May 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 23, 2023REFUSAL PROCESSED BY IB
Friday, November 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, January 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sunday, December 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 17, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, February 5, 2024NOTIFICATION PROCESSED BY IB
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED